Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Haematology|August 17, 2015
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phaseRoberto Latagliata, Chiara Montagna, Raffaele Porrini, et al.
Ejhaem|July 18, 2022
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio groupFrancesca Fazio, Luca Franceschini, Valeria Tomarchio, et al.
Cancer|July 13, 2012
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic formAngela Rago, Sara Grammatico, Tommaso Za, et al.
British Journal of Haematology|December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patientsTommaso Za, Valerio De Stefano, Elena Rossi, et al.
American Journal of Hematology|February 1, 2014
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patientsMarco Montanaro, Roberto Latagliata, Michele Cedrone, et al.
Annals of Hematology|October 11, 2025
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experienceAngela Rago, Francesca Fioritoni, Carmine Liberatore, et al.
Leukemia Research|February 1, 2015
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosisAngela Rago, Roberto Latagliata, Marco Montanaro, et al.
American Journal of Hematology|January 11, 2016
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patientsAlessandro Andriani, Roberto Latagliata, Barbara Anaclerico, et al.
Cancer Medicine|May 26, 2017
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemiaCristina Santoro, Isabella Sperduti, Roberto Latagliata, et al.
Blood|July 12, 2019
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 studyStefano Luminari, Michele Merli, Sara Rattotti, et al.
Pageof 5